History of poliomyelitis Hospital, successfully cultivated the poliovirus in human tissue. This significant breakthrough ultimately allowed for the development of the polio vaccines. Enders and his colleagues, Thomas H. Weller and Frederick C. Robbins, were recognized for their labors with the Nobel Prize in 1954. Two vaccines are used throughout the world to combat polio. The first was developed by Jonas Salk, first tested in 1952, and announced to the world by Salk on April 12, 1955. The Salk vaccine, or "inactivated poliovirus vaccine" (IPV), consists of an injected dose of killed poliovirus. In 1954, the vaccine was tested for its ability to
Salk Institute for Biological Studies Elizabeth Blackburn, Sydney Brenner, and Roger Guillemin. Three of Salk's 11 Nobel laureates are now deceased: Francis Crick, Robert W. Holley, and Renato Dulbecco. Another five scientists trained at Salk have gone on to win Nobel prizes. The institute is organized into several research units, each of which is further composed of several scientific groups, each led by a member of the faculty. Some of these units are: Elizabeth Blackburn is the President of the Salk Institute since 1 January 2016. Edward Callaway is the chair of the academic council. There are 56 faculty members. Six of these are members